Skip to main content
. 2019 Jun;60(6):745–751. doi: 10.2967/jnumed.118.216796

FIGURE 5.

FIGURE 5.

Receiver-operating-characteristic curve for pharmacokinetic rate-constant k3 (A) and SUVmax (B). This curve was constructed from k3 and SUVmax of cluster 1 tumors vs. other (cluster 2 and sporadic) tumors in patients with PPGL. Diagonal line represents line of no discrimination.